BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
You have strategic business objectives. We have the network and expertise to help you realize your goals. We assemble a team that works closely with you to develop a customized investment solution.
Together, we can design a tailored investment approach to support corporate or family office initiatives, market expansion objectives, business development strategies, or any other focused business goals you have in mind.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.